Moneycontrol
HomeNewsBusinessSwiss withdrawal of MFN status to raise costs for some Indian pharma, IT firms: GTRI
Trending Topics

Swiss withdrawal of MFN status to raise costs for some Indian pharma, IT firms: GTRI

Indian firms operating in Switzerland will have to pay a 10-percent tax on dividends and other incomes from January 1, 2025, higher than the earlier rate of 5-percent.

December 13, 2024 / 21:39 IST
Story continues below Advertisement

Switzerland's decision follows an Indian Supreme Court ruling in the Nestlé case back in October 2023, which clarified India’s interpretation around the MFN clause.

The Swiss government's withdrawal of the most favoured nation (MFN) clause in the Double Taxation Avoidance Agreement (DTAA) with India will raise costs for Indian firms operating in Switzerland, particularly for those in financial services, pharmaceuticals, and IT, according to a brief by the think-tank Global Trade Research Initiative.

These firms will have to pay a 10-percent tax on dividends and other incomes from January 1, 2025, higher than the earlier rate of 5-percent.

Story continues below Advertisement

"With the reversion to a 10-percent residual rate starting January 1, 2025, these firms face higher tax liabilities, reducing their competitiveness compared to businesses from countries still benefiting from MFN provisions," said GTRI's founder Ajay Srivastava.

Switzerland's decision follows an Indian Supreme Court ruling in the Nestlé case back in October 2023, which clarified India’s interpretation around the MFN clause.